Center Laboratories, Inc. (4123.TWO)
TWD 35.35
(-2.62%)
TWD 35.35
(-2.62%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.39 Billion TWD | 81.58% |
| 2022 | 767.72 Million TWD | 53.51% |
| 2021 | 500.1 Million TWD | -30.25% |
| 2020 | 717.04 Million TWD | -50.12% |
| 2019 | 1.43 Billion TWD | -93.36% |
| 2018 | 21.64 Billion TWD | 11.64% |
| 2017 | 19.39 Billion TWD | 28.94% |
| 2016 | 15.03 Billion TWD | 121.43% |
| 2015 | 6.79 Billion TWD | 655.74% |
| 2014 | 898.75 Million TWD | 21.14% |
| 2013 | 741.93 Million TWD | 3.95% |
| 2012 | 713.74 Million TWD | 4.28% |
| 2011 | 684.43 Million TWD | 20.28% |
| 2010 | 569.03 Million TWD | 23.11% |
| 2009 | 462.22 Million TWD | 26.8% |
| 2008 | 364.51 Million TWD | 21.62% |
| 2007 | 299.71 Million TWD | 18.19% |
| 2006 | 253.57 Million TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 413.41 Million TWD | 13.76% |
| 2024 Q1 | 363.41 Million TWD | -10.39% |
| 2023 Q2 | 312.3 Million TWD | -6.78% |
| 2023 Q4 | 405.52 Million TWD | 18.86% |
| 2023 Q3 | 341.16 Million TWD | 9.24% |
| 2023 FY | 1.39 Billion TWD | 81.58% |
| 2023 Q1 | 335.01 Million TWD | 40.35% |
| 2022 Q3 | 172.37 Million TWD | -15.77% |
| 2022 Q2 | 204.64 Million TWD | 34.63% |
| 2022 Q4 | 238.69 Million TWD | 38.47% |
| 2022 FY | 767.72 Million TWD | 53.51% |
| 2022 Q1 | 152 Million TWD | 25.33% |
| 2021 FY | 500.1 Million TWD | -30.25% |
| 2021 Q3 | 87.87 Million TWD | -33.71% |
| 2021 Q4 | 121.28 Million TWD | 38.02% |
| 2021 Q2 | 132.56 Million TWD | -16.3% |
| 2021 Q1 | 158.37 Million TWD | -7.91% |
| 2020 Q4 | 171.98 Million TWD | 30.74% |
| 2020 Q3 | 131.54 Million TWD | 25.41% |
| 2020 Q2 | 104.88 Million TWD | -66.02% |
| 2020 FY | 717.04 Million TWD | -50.12% |
| 2020 Q1 | 308.63 Million TWD | -18.49% |
| 2019 FY | 1.43 Billion TWD | -93.36% |
| 2019 Q2 | 351.82 Million TWD | -2.4% |
| 2019 Q3 | 346.71 Million TWD | -1.45% |
| 2019 Q4 | 378.64 Million TWD | 9.21% |
| 2019 Q1 | 360.48 Million TWD | -86.3% |
| 2018 Q2 | 7.11 Billion TWD | 20.76% |
| 2018 FY | 21.64 Billion TWD | 11.64% |
| 2018 Q4 | 2.63 Billion TWD | -56.23% |
| 2018 Q3 | 6.01 Billion TWD | -15.49% |
| 2018 Q1 | 5.89 Billion TWD | 0.12% |
| 2017 Q4 | 5.88 Billion TWD | 16.24% |
| 2017 FY | 19.39 Billion TWD | 28.94% |
| 2017 Q2 | 4.63 Billion TWD | 21.83% |
| 2017 Q3 | 5.06 Billion TWD | 9.12% |
| 2017 Q1 | 3.8 Billion TWD | -15.54% |
| 2016 Q4 | 4.5 Billion TWD | 28.0% |
| 2016 FY | 15.03 Billion TWD | 121.43% |
| 2016 Q3 | 3.52 Billion TWD | -6.07% |
| 2016 Q2 | 3.74 Billion TWD | 15.03% |
| 2016 Q1 | 3.25 Billion TWD | -18.71% |
| 2015 FY | 6.79 Billion TWD | 655.74% |
| 2015 Q1 | 247.57 Million TWD | 1.72% |
| 2015 Q3 | 2.25 Billion TWD | 689.95% |
| 2015 Q4 | 4 Billion TWD | 78.21% |
| 2015 Q2 | 284.83 Million TWD | 15.05% |
| 2014 Q3 | 232.32 Million TWD | 5.26% |
| 2014 FY | 898.75 Million TWD | 21.14% |
| 2014 Q4 | 243.38 Million TWD | 4.76% |
| 2014 Q2 | 220.71 Million TWD | 9.09% |
| 2014 Q1 | 202.33 Million TWD | -11.07% |
| 2013 Q3 | 173.27 Million TWD | 0.73% |
| 2013 FY | 741.93 Million TWD | 3.95% |
| 2013 Q1 | 169.1 Million TWD | -5.49% |
| 2013 Q2 | 172.02 Million TWD | 1.73% |
| 2013 Q4 | 227.53 Million TWD | 31.31% |
| 2012 Q4 | 178.91 Million TWD | 6.37% |
| 2012 FY | 713.74 Million TWD | 4.28% |
| 2012 Q1 | 187.95 Million TWD | 6.66% |
| 2012 Q2 | 178.67 Million TWD | -4.94% |
| 2012 Q3 | 168.2 Million TWD | -5.86% |
| 2011 Q3 | 148.22 Million TWD | -1.28% |
| 2011 Q4 | 176.21 Million TWD | 18.88% |
| 2011 FY | 684.43 Million TWD | 20.28% |
| 2011 Q1 | 209.86 Million TWD | 18.59% |
| 2011 Q2 | 150.13 Million TWD | -28.46% |
| 2010 Q1 | 124.2 Million TWD | 0.0% |
| 2010 Q2 | 139.15 Million TWD | 12.04% |
| 2010 Q4 | 176.96 Million TWD | 37.5% |
| 2010 FY | 569.03 Million TWD | 23.11% |
| 2010 Q3 | 128.7 Million TWD | -7.51% |
| 2009 FY | 462.22 Million TWD | 26.8% |
| 2008 FY | 364.51 Million TWD | 21.62% |
| 2007 FY | 299.71 Million TWD | 18.19% |
| 2006 FY | 253.57 Million TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Allied Biotech Corporation | 720.43 Million TWD | -93.496% |
| GeneFerm Biotechnology Co., Ltd. | 793.77 Million TWD | -75.619% |
| Easywell Biomedicals, Inc. | 271.62 Million TWD | -413.205% |
| TTY Biopharm Company Limited | 5.5 Billion TWD | 74.68% |
| Synmosa Biopharma Corporation | 5.14 Billion TWD | 72.882% |
| Orient EuroPharma Co., Ltd. | 4.59 Billion TWD | 69.642% |
| Tien Liang BioTech Co., Ltd. | 459.99 Million TWD | -203.05% |
| Orient Pharma Co., Ltd. | 889.91 Million TWD | -56.646% |
| InnoPharmax Inc. | 46.07 Million TWD | -2925.651% |
| Johnson Chemical Pharmaceutical Works Co., Ltd. | 606.71 Million TWD | -129.765% |
| Excelsior Biopharma Inc. | 771.56 Million TWD | -80.673% |
| DV Biomed Co., Ltd. | 1.53 Billion TWD | 9.383% |
| Foresee Pharmaceuticals Co., Ltd. | 195.03 Million TWD | -614.737% |
| Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | -26.004% |
| UniPharma Co., Ltd. | 103.22 Million TWD | -1250.495% |
| Anxo Pharmaceutical Co., Ltd. | 939.94 Million TWD | -48.308% |
| Alar Pharmaceuticals Inc. | 469.27 Million TWD | -197.058% |
| Winston Medical Supply Co., Ltd. | 709.07 Million TWD | -96.596% |
| Mercury Biopharmaceutical Corporation | 1.03 Million TWD | -134847.531% |
| Bioray Biotech Co., Ltd | 191.83 Million TWD | -626.689% |
| TSH Biopharm Corporation Limited | 810.91 Million TWD | -71.905% |